Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 36.1 USD 0.61% Market Closed
Market Cap: 571.1m USD

Wall Street
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 39.02 USD with a low forecast of 29.29 USD and a high forecast of 52.5 USD.

Lowest
Price Target
29.29 USD
19% Downside
Average
Price Target
39.02 USD
8% Upside
Highest
Price Target
52.5 USD
45% Upside
Assembly Biosciences Inc Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
13% Upside
PTCT
PTC Therapeutics Inc
10% Upside
REGN
Regeneron Pharmaceuticals Inc
7% Upside
TLX
Telix Pharmaceuticals Ltd
106% Upside
KRYS
Krystal Biotech Inc
7% Downside
VCEL
Vericel Corp
56% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside
TNG
Transgene SA
71% Upside

Revenue
Forecast

Revenue Estimate
Assembly Biosciences Inc

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 4 years is 0%.

N/A
Past Growth
0%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASMB's stock price target?
Price Target
39.02 USD

According to Wall Street analysts, the average 1-year price target for ASMB is 39.02 USD with a low forecast of 29.29 USD and a high forecast of 52.5 USD.

What is Assembly Biosciences Inc's Revenue forecast?
Projected CAGR
0%

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 4 years is 0%.

Back to Top